Published in Pharm Res on October 01, 1999
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest (2002) 1.90
HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol (2001) 1.15
ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut (2003) 1.10
Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J (2003) 1.09
Ivermectin excretion by isolated functionally intact brain endothelial capillaries. Br J Pharmacol (2001) 0.92
P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. Br J Pharmacol (2000) 0.83
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Generation in vitro of deletions in the broad host range plasmid RK2 using phage Mu insertions and a restriction endonuclease. Gene (1976) 4.35
Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med (1992) 4.02
Mortality rates in displaced and resident populations of central Somalia during 1992 famine. Lancet (1993) 3.84
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med (1994) 3.61
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
Changing patterns in epidemiology of Crohn's disease. Lancet (1974) 2.99
Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ (1999) 2.77
Attitudes toward clinical trials among patients and the public. JAMA (1982) 2.53
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Actinomycin D: inhibition of respiration and glycolysis. Science (1966) 2.47
The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. AJR Am J Roentgenol (1998) 2.24
Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Engl J Med (1984) 2.24
Transient neurologic symptoms after spinal anesthesia. Anesth Analg (1995) 2.15
After the hospital episode. Lancet (1975) 2.11
Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health (2000) 1.99
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med (1992) 1.85
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol (1999) 1.77
Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut (1999) 1.69
The measurement of food and energy intake in man-an evaluation of some techniques. Am J Clin Nutr (1980) 1.68
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 1.67
Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis. Neurosci Biobehav Rev (2010) 1.65
Effects of ondansetron in the prevention of postoperative nausea and vomiting in children. Anesthesiology (1994) 1.65
The Rand Health Insurance Study: a summary critique. Med Care (1987) 1.65
Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol (2000) 1.63
Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med (1986) 1.63
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Gluttony. 1. An experimental study of overeating low- or high-protein diets. Am J Clin Nutr (1967) 1.57
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology (1996) 1.55
The demographic and social characteristics of patients with Crohn's disease in the Nottingham area. Scand J Gastroenterol (1976) 1.54
Lamivudine therapy of WHV-infected woodchucks. Virology (1998) 1.52
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol (1999) 1.52
HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol (1999) 1.51
Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst (1998) 1.50
Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol (1995) 1.49
Psychosocial correlates of survival in advanced malignant disease? N Engl J Med (1985) 1.48
Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology (1994) 1.48
Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol (2001) 1.48
Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev (1993) 1.45
Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr (1989) 1.42
A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine. Anesth Analg (1996) 1.41
The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr (2011) 1.41
Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening. Acta Anaesthesiol Scand (1992) 1.40
Multicystic ovarian tumor weighing 156 lbs: the second largest tumor in Texas. Tex Med (1997) 1.39
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab (2001) 1.37
Artifacts caused by cell microinjection. Proc Natl Acad Sci U S A (1984) 1.35
Gluttony. 2. Thermogenesis in overeating man. Am J Clin Nutr (1967) 1.33
The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. Curr Pharm Des (2009) 1.31
Helicobacter pylori infection in healthy people: a dynamic process? Gut (1991) 1.31
P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am J Physiol (1995) 1.30
Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum Mol Genet (1998) 1.29
The vascular architecture of the different forms of small intestinal villi in the rat (Rattus norvegicus). Scand J Gastroenterol (1969) 1.29
Resistance to slimming: adaptation or illusion? Lancet (1975) 1.27
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child (1984) 1.26
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut (2000) 1.23
Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology (1998) 1.22
Lesions of the brachial plexus associated with fractures of the clavicle. Clin Orthop Relat Res (1969) 1.20
Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.18
A psychological analysis of cancer patients and their next-of-kin. Cancer (1985) 1.17
Patterns of inpatient surgeries for the top four cancers in the United States, National Hospital Discharge Survey, 1988-95. Cancer Causes Control (2000) 1.16
The Ethiopia applied nutrition project. Proc R Soc Lond B Biol Sci (1976) 1.15
HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol (2001) 1.15
Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol (1998) 1.13
Intracellular compartmentalization of adenosine triphosphate. J Biol Chem (1986) 1.13
The oocyte nucleus isolated in oil retains in vivo structure and functions. Biotechniques (1992) 1.12
Potential role of membrane internalization and vesicle fusion in adhesion of neutrophils in response to lipopolysaccharide and TNF. J Immunol (1996) 1.11
Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells. Regul Pept (2007) 1.11
Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976-1996. Cancer (2000) 1.10
Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol (1991) 1.10
Comparative nutrition, growth and longevity. Proc Nutr Soc (1968) 1.09
Failure to thrive. A continuing problem of definition. Clin Pediatr (Phila) (1989) 1.09
Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br J Pharmacol (1996) 1.08
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Solvent properties of ground substance studied by cryomicrodissection and intracellular reference-phase techniques. J Cell Biol (1984) 1.07
Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants. Gynecol Oncol (2000) 1.07
Non-specific and specific immunotherapy in patients with melanoma. Surgery (1972) 1.06
Genetic influences on exercise-induced adult hippocampal neurogenesis across 12 divergent mouse strains. Genes Brain Behav (2011) 1.05
Multiple pathways of organic anion secretion in renal proximal tubule revealed by confocal microscopy. Am J Physiol (1996) 1.05
A new member of the team? Extending the role of the nurse in British primary care. Lancet (1980) 1.04
p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubule. J Pharmacol Exp Ther (1997) 1.04
Bupivacaine concentrations in the lumbar cerebrospinal fluid of patients during spinal anaesthesia. Br J Anaesth (2009) 1.03
Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg Med Chem Lett (2001) 1.03
The daily metabolic rate of the post-obese and the lean. Am J Clin Nutr (1987) 1.03
Transfusion medicine in obstetrics and gynecology. Obstet Gynecol Surv (1995) 1.02
Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res (1999) 1.01
Energy balances in obese mice. Nutr Metab (1979) 1.01
Energy balance following sympathetic denervation of brown adipose tissue. Can J Physiol Pharmacol (1984) 1.01
Polymorphonuclear leukocyte phagocytosis: quantitation by a rapid radioactive method. J Lab Clin Med (1975) 1.00
Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am J Physiol Regul Integr Comp Physiol (2001) 1.00
Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection. BMJ (1999) 1.00
Prediction of adverse drug reactions using decision tree modeling. Clin Pharmacol Ther (2010) 0.99
Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts. J Immunol (1987) 0.99